Analysts/Institutional Investor Meet/Con. Call Updates

August 21, 2026 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai-400001 Symbol: ORCHPHARMA Scrip Code: 524372 Ref: (i) Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (ii)SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sub: Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited (“the Company”) Dear Sir/Madam, With reference to the above captioned subject and pursuant to Regulation 30, Sub- para 15 of Para A Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI Circular no. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 and in continuation to earlier intimations dated August 17 & 20, 2026 for Analysts/ Investors Earnings Call, we would like to inform you that the Audio Recording of the Analysts/Investors Earnings Call held today i.e. August 21, 2026 at 15:00 P.M. (IST) to discuss the Unaudited Limited Reviewed Financial Results (Standalone and Consolidated) for the Quarter- I of Financial Year 2026-27, ended on June 30, 2026, has been uploaded on the website of the Company. Please find below the link to the Audio Recording of the same: Link: https://orchid-pharma.b-cdn.net/audios/Concall_Recording_Q-1_June30%2C2026.mp3 This is to confirm that the Analysts/Investors Earnings call was held through Audio Conference call and no Video Recording is available for same. You are requested to take the above on your record. Thanking You, For Orchid Pharma Limited Kapil Dayya Company Secretary & Compliance Officer Mem. No.: F10698